Collectively, our findings indicate that AMPK plays a critical role in the regulation of energy homeostasis and chronic AMPK activation may provide promising therapeutics for treating of obesity and related metabolic diseases through promoting energy expenditure. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.